Tilray’s products will treat patients with neuropathic pain, epilepsy and multiple sclerosis who aren’t getting relief from existing treatments. Source
Tilray stock soars 10% after company tapped to provide medical cannabis in French study
According to copyright-related laws, copy any of our content for publication should indicate the source and link of us, such as:"source: NCOV Live Update", otherwise we have the right to hold accountable.